Skip to main content

Advertisement

Table 1 Characteristics of patients with non-small-cell lung cancer (NSCLC) who completed the SF-36 and QLQ C-30 health-related quality of life (HRQoL) surveys

From: Quality of life after the initial treatments of non-small cell lung cancer: a persistent predictor for patients’ survival

  SF-36 (n = 230) QLQ C-30 (n = 230)
  Mean ± SD n [%] Mean ± SD n [%]
Age 60.2 ± 10.7   60.1 ± 10.7  
Sex:     
  - Men   186 [80.9]   184 [80.0]
  - Women   44 [19.1]   46 [20.0]
Stage of cancer     
  - I or II   49 [21.3]   48 [20.9]
  - III   136 [59.1]   141 [61.3]
  - IV   45 [19.6]   41 [17.8]
Treatments before the HRQoL measurement   
  - Chemotherapy only 133 [57.8)   132 [57.4]
  - Radiotherapy only or with chemotherapy 26 [11.3]   24 [10.4]
  - Surgery alone or surgery and (radiotherapy or chemotherapy) 71 [30.9]   74 [32.2]
Education level     
  - Primary   64 [28.7]   64 [29.6]
  - Secondary   144 [64.6]   136 [63.0]
  - Post-secondary   15 [6.7]   16 [7.4]
  1. SF-36 = Medical Outcomes Survey Short Form 36; QLQ C-30 = European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core-30.
  2. Treatments before HRQoL measurement were divided into 3 classes for all Cox multivariate models:
  3. 1) Chemotherapy only.
  4. 2) Radiotherapy or chemotherapy or both.
  5. 3) Surgery alone or surgery and radiotherapy or chemotherapy.